Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tadataka Yamada M.D.

Chief Medical & Scientific Officer and Director, Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 128 board members in 7 different organizations across 11 different industries.

See Board Relationships
68--

Background*

Dr. Tadataka Yamada, also known as Tachi, M.D., has been Corporate Officer and Head of Emerging Markets Commercial Operations for Nycomed A/S at Takeda Pharmaceutical Company Limited. Dr. Yamada served as an Executive Vice President and Medical and Scientific Advisor to the Chief Executive Officer of Takeda Pharmaceutical Company Limited. Dr. Yamada serves as an Executive Vice President and Medical and Scientific Advisor to the CEO at Takeda Pharmaceuticals International ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

Director
Former Director and Member of Audit Coommittee
Former Director
Trustee
Director
Trustee
Director
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
1997-N/A
Former Director
2004-2006
Former Chairman of Research & Development, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Financial Results Committee
2007-2011
Former Director, Member of Compliance Committee and Member of Nominating & Governance Committee
2011-Present
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
2011-Present
Chief Medical & Scientific Officer and Director

Education*

BA
The Leland Stanford Junior University
MD
New York University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,713.00 JPY +39.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Karl-Ludwig Kley Chairman of Executive Board
Merck KGaA
€5.4M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.